ULK1, a novel therapeutic target to delay drug tolerance to EGFR–TKIs in an EGFR-mutant non-small cell lung cancer model

作者：Ayako Morita, Kammei Rai, Tadahiro Kuribayashi, Shuta Tomida, Tatsuya Nishi, Naofumi Hara, Go Makimoto, Kiichiro Ninomiya, Toshio Kubo, Kadoaki Ohashi, Katsuyuki Hotta, Nobuaki Ochi, Yosuke Togashi, Yoshinobu Maeda, Eiki Ichihara · 发表于：Lung Cancer · 年份：2026 · DOI：10.1016/j.lungcan.2026.109516 · 研究领域：Lung Cancer Treatments and Mutations、NF-κB Signaling Pathways、PI3K/AKT/mTOR signaling in cancer